Anti-Follistatin 288 [29/9]

29/9 is a clone raised against recombinant Fst 288, and is used in combination, commonly as the capture, with antibody 17/2 in a two site ELISA for the detection of Follistatin.

Contributors

Institute
BioServ UK Ltd
SKU: 153636
Product description: Follistatin is a single-chain glycosylated protein that inhibits follicle stimulating hormone (FSH) release. Alternative splicing of Follistatin mRNA yields two isoforms, FS315 and FS288. FS288 is the main cell-surface form and binds to surface heparin sulphate proteoglycans. 29/9 is a clone raised against recombinant Fst 288, and is used in combination, commonly as the capture, with antibody 17/2 in a two site ELISA for the detection of Follistatin.
Alternate name: Follistatin, FS, FST, Active-binding protein
Conjugation: Unconjugated
Isotype: IgG1
Molecular weight: 37 kDa
Immunogen: Raised to human Follistatin (Fst) 288 and recognizes both human Fst 288 and 315
Myeloma used: Sp2/0-Ag14
Cat. #: 153636
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Apoptosis and autophagy; Cancer; Cell signaling and signal transduction; Genetics
Application: ELISA
Target: Follistation 288
Reactivity: Human
Clone: 3.222222222
Host: Mouse
Class: Monoclonal
Target background: Follistatin is a single-chain glycosylated protein that inhibits follicle stimulating hormone (FSH) release. Alternative splicing of Follistatin mRNA yields two isoforms, FS315 and FS288. FS288 is the main cell-surface form and binds to surface heparin sulphate proteoglycans. 29/9 is a clone raised against recombinant Fst 288, and is used in combination, commonly as the capture, with antibody 17/2 in a two site ELISA for the detection of Follistatin.
Format: Liquid
Shipping conditions: Dry ice
References:

Hughes et al. 2003. Eur J Gastroenterol Hepatol. 15(2):127-31. PMID: 12560755.

Activin A and follistatin in acute liver failure.

Yuen et al. 2002. Scand J Gastroenterol. 37(2):233-8. PMID: 11843063.

Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis.

Menon et al. 2000. BJOG. 107(9):1069-74. PMID: 11002947.

Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma.

McPherson et al. 1999. Endocrinology. 140(11):5303-9. PMID: 10537161.

Expression of activin A and follistatin core proteins by human prostate tumor cell lines.

Cuckle et al. 1999. Prenat Diagn. 19(6):513-6. PMID: 10416964.

Maternal serum activin A and follistatin levels in pregnancies with Down syndrome.

Fowler et al. 1998. Hum Reprod. 13(12):3530-6. PMID: 9886545.

Anderson et al. 1998. Hum Reprod. 13(12):3319-25. PMID: 9886507.

Follistatin and activin A production by the male reproductive tract.

A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy.

Riley et al. 1998. Hum Reprod. 13(9):2624-8. PMID: 9806296.

Follistatin and activin A in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy.

Evans et al. 1998. J Endocrinol. 156(2):275-82. PMID: 9518873.

Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin.

Petraglia et al. 1997. J Clin Endocrinol Metab. 82(9):2991-5. PMID: 9284732.

Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases.

Images

View Gallery

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.